vs
FIRST US BANCSHARES, INC.（FUSB）与SUTRO BIOPHARMA, INC.（STRO）财务数据对比。点击上方公司名可切换其他公司
SUTRO BIOPHARMA, INC.的季度营收约是FIRST US BANCSHARES, INC.的1.1倍（$11.6M vs $10.4M），FIRST US BANCSHARES, INC.同比增速更快（7.1% vs -21.4%），过去两年FIRST US BANCSHARES, INC.的营收复合增速更高（2.6% vs -5.4%）
第一美国银行控股公司是一家银行控股企业，核心子公司第一公民银行在美国23个州经营着超过500家网点，另一家子公司硅谷银行则在15个州设有39个办事处，是美国规模较大的银行机构之一，总部位于北卡罗来纳州罗利。
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
FUSB vs STRO — 直观对比
营收规模更大
STRO
是对方的1.1倍
$10.4M
营收增速更快
FUSB
高出28.4%
-21.4%
两年增速更快
FUSB
近两年复合增速
-5.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.4M | $11.6M |
| 净利润 | $2.1M | — |
| 毛利率 | — | — |
| 营业利润率 | 28.1% | — |
| 净利率 | 20.4% | — |
| 营收同比 | 7.1% | -21.4% |
| 净利润同比 | 24.2% | 35.4% |
| 每股收益（稀释后） | $0.36 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FUSBSTRO
| Q4 25 | $10.4M | $11.6M | ||
| Q3 25 | $10.5M | $9.7M | ||
| Q2 25 | $10.3M | $63.7M | ||
| Q1 25 | $9.8M | $17.4M | ||
| Q4 24 | $9.7M | $14.8M | ||
| Q3 24 | $10.1M | $8.5M | ||
| Q2 24 | $10.0M | $25.7M | ||
| Q1 24 | $9.9M | $13.0M |
净利润FUSBSTRO
| Q4 25 | $2.1M | — | ||
| Q3 25 | $1.9M | $-56.9M | ||
| Q2 25 | $155.0K | $-11.5M | ||
| Q1 25 | $1.8M | $-76.0M | ||
| Q4 24 | $1.7M | $-72.4M | ||
| Q3 24 | $2.2M | $-48.8M | ||
| Q2 24 | $2.1M | $-48.0M | ||
| Q1 24 | $2.1M | $-58.2M |
营业利润率FUSBSTRO
| Q4 25 | 28.1% | — | ||
| Q3 25 | 23.9% | -499.9% | ||
| Q2 25 | 1.6% | -5.2% | ||
| Q1 25 | 23.8% | -393.8% | ||
| Q4 24 | 23.8% | -440.7% | ||
| Q3 24 | 29.2% | -797.2% | ||
| Q2 24 | 27.4% | -189.4% | ||
| Q1 24 | 27.8% | -435.0% |
净利率FUSBSTRO
| Q4 25 | 20.4% | — | ||
| Q3 25 | 18.4% | -586.6% | ||
| Q2 25 | 1.5% | -18.0% | ||
| Q1 25 | 18.1% | -436.6% | ||
| Q4 24 | 17.6% | -489.2% | ||
| Q3 24 | 22.0% | -572.6% | ||
| Q2 24 | 21.2% | -186.8% | ||
| Q1 24 | 21.3% | -447.5% |
每股收益（稀释后）FUSBSTRO
| Q4 25 | $0.36 | — | ||
| Q3 25 | $0.32 | $-0.67 | ||
| Q2 25 | $0.03 | $-0.14 | ||
| Q1 25 | $0.29 | $-0.91 | ||
| Q4 24 | $0.29 | $-27.63 | ||
| Q3 24 | $0.36 | $-0.59 | ||
| Q2 24 | $0.34 | $-0.59 | ||
| Q1 24 | $0.34 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $73.5M | $141.4M |
| 总债务越低越好 | $10.9M | — |
| 股东权益账面价值 | $105.6M | $-132.5M |
| 总资产 | $1.2B | $173.8M |
| 负债/权益比越低杠杆越低 | 0.10× | — |
8季度趋势，按日历期对齐
现金及短期投资FUSBSTRO
| Q4 25 | $73.5M | $141.4M | ||
| Q3 25 | $54.7M | $167.6M | ||
| Q2 25 | $54.0M | $205.1M | ||
| Q1 25 | $56.0M | $249.0M | ||
| Q4 24 | $47.2M | $316.9M | ||
| Q3 24 | $82.3M | $388.3M | ||
| Q2 24 | $58.2M | $375.6M | ||
| Q1 24 | $60.2M | $267.6M |
总债务FUSBSTRO
| Q4 25 | $10.9M | — | ||
| Q3 25 | $10.9M | — | ||
| Q2 25 | $10.9M | — | ||
| Q1 25 | $10.9M | — | ||
| Q4 24 | $10.9M | — | ||
| Q3 24 | $10.9M | — | ||
| Q2 24 | $10.8M | — | ||
| Q1 24 | $10.8M | — |
股东权益FUSBSTRO
| Q4 25 | $105.6M | $-132.5M | ||
| Q3 25 | $104.2M | $-87.3M | ||
| Q2 25 | $101.9M | $-32.1M | ||
| Q1 25 | $101.2M | $-25.8M | ||
| Q4 24 | $98.6M | $44.6M | ||
| Q3 24 | $98.5M | $111.2M | ||
| Q2 24 | $93.8M | $152.2M | ||
| Q1 24 | $92.3M | $98.0M |
总资产FUSBSTRO
| Q4 25 | $1.2B | $173.8M | ||
| Q3 25 | $1.1B | $209.7M | ||
| Q2 25 | $1.1B | $262.4M | ||
| Q1 25 | $1.1B | $321.4M | ||
| Q4 24 | $1.1B | $387.2M | ||
| Q3 24 | $1.1B | $451.8M | ||
| Q2 24 | $1.1B | $489.0M | ||
| Q1 24 | $1.1B | $403.4M |
负债/权益比FUSBSTRO
| Q4 25 | 0.10× | — | ||
| Q3 25 | 0.10× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | 0.11× | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.12× | — | ||
| Q1 24 | 0.12× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.3M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | $9.1M | — |
| 自由现金流率自由现金流/营收 | 87.2% | — |
| 资本支出强度资本支出/营收 | 31.1% | — |
| 现金转化率经营现金流/净利润 | 5.79× | — |
| 过去12个月自由现金流最近4个季度 | $16.0M | — |
8季度趋势，按日历期对齐
经营现金流FUSBSTRO
| Q4 25 | $12.3M | $-177.2M | ||
| Q3 25 | $4.2M | $-38.2M | ||
| Q2 25 | $3.9M | $-44.7M | ||
| Q1 25 | $1.8M | $-67.9M | ||
| Q4 24 | $7.8M | $-71.7M | ||
| Q3 24 | $1.9M | $-64.5M | ||
| Q2 24 | $2.5M | $9.5M | ||
| Q1 24 | $825.0K | $-64.7M |
自由现金流FUSBSTRO
| Q4 25 | $9.1M | — | ||
| Q3 25 | $3.6M | — | ||
| Q2 25 | $1.6M | — | ||
| Q1 25 | $1.7M | — | ||
| Q4 24 | $5.7M | — | ||
| Q3 24 | $1.3M | — | ||
| Q2 24 | $2.3M | — | ||
| Q1 24 | $-142.0K | — |
自由现金流率FUSBSTRO
| Q4 25 | 87.2% | — | ||
| Q3 25 | 34.2% | — | ||
| Q2 25 | 16.0% | — | ||
| Q1 25 | 17.2% | — | ||
| Q4 24 | 58.2% | — | ||
| Q3 24 | 12.7% | — | ||
| Q2 24 | 23.5% | — | ||
| Q1 24 | -1.4% | — |
资本支出强度FUSBSTRO
| Q4 25 | 31.1% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 21.8% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 21.6% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | 9.8% | — |
现金转化率FUSBSTRO
| Q4 25 | 5.79× | — | ||
| Q3 25 | 2.18× | — | ||
| Q2 25 | 25.16× | — | ||
| Q1 25 | 0.99× | — | ||
| Q4 24 | 4.53× | — | ||
| Q3 24 | 0.87× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 0.39× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
